Bactiguard Holding AB (LTS:0QV2) EBIT : kr-125.2 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Bactiguard Holding AB EBIT?

Bactiguard Holding AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was kr-8.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-125.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bactiguard Holding AB's annualized ROC % for the quarter that ended in Mar. 2024 was -6.61%. Bactiguard Holding AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -32.33%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Bactiguard Holding AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -4.91%.

Bactiguard Holding AB EBIT Historical Data

The historical data trend for Bactiguard Holding AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bactiguard Holding AB EBIT Chart

Bactiguard Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

18.26

-33.12

-54.88

-51.16

-133.63

Bactiguard Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															-16.76	-62.07	-19.38	-35.42	-8.33

Competitive Comparison of Bactiguard Holding AB's EBIT

For the Medical Devices subindustry, Bactiguard Holding AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bactiguard Holding AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bactiguard Holding AB's EV-to-EBIT falls into.

Bactiguard Holding AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-125.2 Mil.

Bactiguard Holding AB (LTS:0QV2) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bactiguard Holding AB's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-51.468 * ( 1 - 18.84% )	/	( (707.724	+	556.992)	/ 2 )
=	-41.7714288	/	632.358
=	-6.61 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	662.174	-	17.729	-	( 123.217	-	max(0, 261.406	-	198.127	+	123.217	))
=	707.724

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	669.428	-	19.757	-	( 95.839	-	max(0, 99.034	-	191.713	+	95.839	))
=	556.992

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Bactiguard Holding AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-33.324	/	( ( (93.858 + max(-20.279, 0))	+	(112.305 + max(-16.129, 0)) )	/	2 )
=	-33.324	/	( ( 93.858	+	112.305 )	/	2 )
=	-33.324	/	103.0815
=	-32.33 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(17.249	+	29.646	+	3.439)	-	(17.729	+	0	+	52.884)
=	-20.279

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(33.647	+	29.337	+	-2.8421709430404E-14)	-	(19.757	+	0	+	59.356)
=	-16.129

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bactiguard Holding AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-125.196	/	2549.701
	=	-4.91 %

Bactiguard Holding AB EBIT Related Terms

Thank you for viewing the detailed overview of Bactiguard Holding AB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bactiguard Holding AB (LTS:0QV2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bactiguard Holding AB (LTS:0QV2) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

BACTI B:Sweden

Address

Alfred Nobels Alle 150, Box 15, Tullinge, SWE, SE 146 21

Website

https://www.bactiguard.com

Bactiguard Holding AB is a Sweden-based medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.

Bactiguard Holding AB (LTS:0QV2) Headlines

No Headlines